Correlation Between 21st Century and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both 21st Century and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 21st Century and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 21st Century Management and Emcure Pharmaceuticals, you can compare the effects of market volatilities on 21st Century and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 21st Century with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 21st Century and Emcure Pharmaceuticals.

Diversification Opportunities for 21st Century and Emcure Pharmaceuticals

0.97

Correlation Coefficient

21st Century  Emcure Pharmaceuticals

Almost no diversification

The 3 months correlation between 21st and Emcure is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding 21st Century Management and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and 21st Century is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 21st Century Management are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of 21st Century i.e., 21st Century and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between 21st Century and Emcure Pharmaceuticals

Assuming the 90 days trading horizon 21st Century Management is expected to under-perform the Emcure Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, 21st Century Management is 1.59 times less risky than Emcure Pharmaceuticals. The stock trades about -0.33 of its potential returns per unit of risk. The Emcure Pharmaceuticals is currently generating about -0.18 of returns per unit of risk over similar time horizon. If you would invest  144,435  in Emcure Pharmaceuticals on December 25, 2024 and sell it today you would lose (38,215) from holding Emcure Pharmaceuticals or give up 26.46% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	98.36%
Values	Daily Returns

21st Century Management  vs.  Emcure Pharmaceuticals

21st Century Management

Risk-Adjusted Performance

Very Weak

Over the last 90 days 21st Century Management has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Emcure Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with 21st Century and Emcure Pharmaceuticals

The main advantage of trading using opposite 21st Century and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 21st Century position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind 21st Century Management and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.